Sintx Technologies (NASDAQ:SINT) & Terumo (OTCMKTS:TRUMY) Head-To-Head Analysis

Terumo (OTCMKTS:TRUMY) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk.

Institutional and Insider Ownership

18.4% of Sintx Technologies shares are held by institutional investors. 8.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Terumo and Sintx Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Terumo	$7.52 billion	2.95	$897.03 million	$0.48	31.35
Sintx Technologies	$1.02 million	9.97	-$10.36 million	($1.69)	-0.80

Terumo has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Terumo, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and price targets for Terumo and Sintx Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Terumo	0	0	0	2	4.00
Sintx Technologies	1	0	3	0	2.50

Sintx Technologies has a consensus price target of $9.50, suggesting a potential upside of 606.32%. Given Sintx Technologies’ higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Terumo.

Profitability

This table compares Terumo and Sintx Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Terumo	9.31%	7.03%	4.83%
Sintx Technologies	-281.91%	-309.86%	-101.90%

Summary

Terumo beats Sintx Technologies on 8 of the 13 factors compared between the two stocks.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

About Sintx Technologies

SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications. In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.